Skip to main content
Equibles

MORGAN STANLEY

Position in HUMA — Humacyte, Inc.

CIK 895421 NEW YORK, NY
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$269,193
+$155,842 QoQ
Shares Held
345,122
+84.8% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 163 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 72% Shared 0% None 28%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. HUMA ranks #308 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in HUMA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $269,193 345,122
2026-03-31 $113,351 186,743
2025-12-31 $2,407,713 2,505,428
2025-09-30 $3,648,349 2,096,753
2025-06-30 $2,877,081 1,376,595
2025-03-31 $989,527 580,370
2024-12-31 $3,109,708 615,784
2024-09-30 $3,042,659 559,313
2024-06-30 $975,026 203,131
2024-03-31 $436,425 140,331
2023-12-31 $436,576 153,725
2023-09-30 $229,431 78,305
2023-06-30 $265,032 92,670
2023-03-31 $233,739 75,645
2022-12-31 $103,510 49,059
2022-09-30 $153,111 46,968
2022-06-30 $128,857 40,143
2022-03-31 $300,775 42,603
2021-12-31 $665,672 91,817
2021-09-30 $839,901 72,343